≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback

Other disorders of prostate

DOID EFO Endpoint Browser PheWeb

N14_PROSTAOTH

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

only males

226837

2. Check conditions

None

226837

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — N42
  • Hospital discharge: ICD-9 — 602
  • Hospital discharge: ICD-8 — 602
  • Cause of death: ICD-10 — N42
  • Cause of death: ICD-9 — 602
  • Cause of death: ICD-8 — 602

2 out of 7 registries used, show all original rules.

1340

4. Check minimum number of events

None

1340

5. Include endpoints

None

1340

6. Filter based on genotype QC (FinnGen only)

1340

Control definitions (FinnGen only)

Control exclude
N14_MALEGEN

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF2
Parent code in ICD-10
N40-N51
Name in latin
Aliae morbositates prostatae

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 10209 - 10209
Only index persons 8368 - 8368
Unadjusted period prevalence (%)
Whole population 0.29 - 0.29
Only index persons 0.32 - 0.32
Median age at first event (years)
Whole population - - 67.24
Only index persons - - 65.98

-FinnGen-

Key figures

All Female Male
Number of individuals 1340 - 1340
Unadjusted period prevalence (%) 0.59 - 0.59
Median age at first event (years) 66.21 - 66.21

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
1192
Matched controls
11919
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
N42.9
ICD-10 Finland
Disorder of prostate, unspecified
1629.3
323.0
991
36
N40
ICD-10 Finland
Hyperplasia of prostate
10.2
253.6
612
1113
XKD00
NOMESCO Finland
Uroflowmetry
9.3
208.0
510
889
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
10.4
202.7
452
663
KE1AT
NOMESCO Finland
Biopsy of prostata with ultrasoudnguidance
10.9
177.3
374
479
C61
ICD-10 Finland
Malignant neoplasm of prostate
7.0
167.3
506
1139
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
6.7
156.4
480
1083
TKE00
NOMESCO Finland
Needle biopsy of prostate
13.0
143.9
270
263
KE1BE
NOMESCO Finland
Rectal ultrasound examinaiton of prostata
11.4
139.1
279
310
KED22
NOMESCO Finland
Transurethral resection of prostate
37.4
133.0
171
53
G04CA02
ATC
tamsulosin; oral
4.5
127.6
680
2704
UKC02
NOMESCO Finland
Cystoscopy
6.1
119.6
382
858
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
5.7
116.6
399
970
XJH00
NOMESCO Finland
Transanal ultrasonography
9.1
95.9
216
284
N42.8
ICD-10 Finland
Other specified disorders of prostate
71.8
92.2
105
16
116
Kela drug reimbursment
Prostate cancer
5.7
91.8
299
661
J01EA01
ATC
trimethoprim; systemic
5.8
89.2
283
604
J01MA02
ATC
ciprofloxacin; systemic
3.1
71.1
577
2766
G04CB02
ATC
dutasteride; oral
6.0
69.6
210
411
R33
ICD-10 Finland
Retention of urine
5.9
65.2
197
385
G04CB01
ATC
finasteride; oral (testosterone-5-alpha reductase inhibitors)
4.0
64.9
304
941
L02BB03
ATC
bicalutamide; oral
7.0
61.6
162
262
L02AE02
ATC
leuprorelin; implant, parenteral
4.8
48.9
176
413
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
4.5
47.4
181
451
R31
ICD-10 Finland
Unspecified haematuria
3.9
46.7
216
643
G04CA01
ATC
alfuzosin; oral
3.1
44.5
283
1077
XA402
NOMESCO Finland
ENMG
10.4
41.5
83
85
YL1AD
NOMESCO Finland
CT examination of pelvis for dose design of radiotherapy
10.3
40.7
82
85
6000A
ICD-9 Finland
Hyperplasia of prostate[HYPERPLASIA PROSTATAE]
+∞
38.7
37
*
N42.0
ICD-10 Finland
Calculus of prostate
+∞
35.6
34
*
G04CA52
ATC
tamsulosin and dutasteride; systemic
3.2
33.0
195
691
XG470
NOMESCO Finland
Measurement of diffusion capastity of the lungs
6.8
31.3
81
126
TKC50
NOMESCO Finland
Training of urinary bladder
320.8
31.0
31
*
KGH10
NOMESCO Finland
Operation for phimosis
56.5
28.3
33
6
R74.8
ICD-10 Finland
Abnormal levels of other serum enzymes
3.3
27.0
146
482
GD1AA
SPAT
NA
5.0
26.9
90
193
N47
ICD-10 Finland
Redundant prepuce, phimosis and paraphimosis
28.5
26.8
36
13
N30.0
ICD-10 Finland
Acute cystitis
4.2
26.6
105
266
FM1DE
NOMESCO Finland
Doppler ultrasound examination of heart
2.9
26.2
177
678
XA420
NOMESCO Finland
Extensive sleep examination
11.3
26.0
49
45
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
2.2
24.4
281
1438
N41.0
ICD-10 Finland
Acute prostatitis
9.4
23.7
49
54
KED33
NOMESCO Finland
Transurethral incision of prostate
17.3
23.7
37
22
R35
ICD-10 Finland
Polyuria
3.8
23.6
103
286
N45.9
ICD-10 Finland
Orchitis, epididymitis and epididymo-orchitis without abscess
14.9
23.5
39
27
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
2.8
23.3
159
614
A29
ICPC
General symptom/complaint other
2.9
23.0
150
562
XKD06
NOMESCO Finland
Physiologic investigation of micturition
7.9
22.7
52
68
WF090
NOMESCO Finland
Profylactic radiotherapy
14.5
22.7
38
27
N41.1
ICD-10 Finland
Chronic prostatitis
10.1
22.7
45
46
WF002
NOMESCO Finland
Radical radiotherapy
3.4
22.0
112
353
N02BE01
ATC
paracetamol; systemic, rectal
1.9
20.7
896
7331
J01MA06
ATC
norfloxacin; oral
3.1
20.5
120
416
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
2.8
20.5
138
526
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
2.0
20.4
328
1915
J01CA08
ATC
pivmecillinam; oral
3.5
20.2
98
297
Z09.0
ICD-10 Finland
Follow-up examination after surgery for other conditions
6.4
19.7
52
84
J01DB01
ATC
cefalexin; oral
1.8
19.7
835
6710
XG460
NOMESCO Finland
Short time oxymetry
5.6
19.4
57
106
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
3.3
19.4
101
324
TKC22
NOMESCO Finland
Catheterisation instruction
10.0
19.2
38
39
KEC01
NOMESCO Finland
Percutaneous endoscopic radical prostatectomy
4.5
19.0
69
162
Z08.1
ICD-10 Finland
Follow-up examination after radiotherapy for malignant neoplasm
16.5
18.4
29
18
Z08.7
ICD-10 Finland
Follow-up examination after combined treatment for malignant neoplasm
16.5
18.4
29
18
UJF32
NOMESCO Finland
Coloscopy
2.0
18.1
293
1704
7451
FHL
Transurethral adenoma removal
33.4
18.0
23
7
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
6.8
18.0
45
68
TKC20
NOMESCO Finland
Catheterisation of bladder
2.7
17.8
124
483
N42.1
ICD-10 Finland
Congestion and haemorrhage of prostate
+∞
17.7
17
*
N35.9
ICD-10 Finland
Urethral stricture, unspecified
9.7
17.5
35
37
A02BC03
ATC
lansoprazole; oral
1.9
17.4
325
1986
7461
FHL
Needle biopsy in the operating room
21.2
17.3
25
12
WX702
NOMESCO Finland
Supraglottic ventilation device
4.1
17.2
69
178
Z00.6
ICD-10 Finland
Examination for normal comparison and control in clinical research programme
8.3
16.8
37
46
R39.1
ICD-10 Finland
Other difficulties with micturition
4.8
16.8
56
121
Z76.8
ICD-10 Finland
Persons encountering health services in other specified circumstances
5.0
16.6
54
113
U02
ICPC
Urinary frequency/urgency
3.5
16.4
79
239
N41.9
ICD-10 Finland
Inflammatory disease of prostate, unspecified
9.4
16.2
33
36
KE3AT
NOMESCO Finland
Transrectal gold marker implantation in prostate under ultrasound guidance
4.5
16.2
58
135
M54.5
ICD-10 Finland
Low back pain
1.9
16.1
274
1613
M01AH05
ATC
etoricoxib; oral
1.7
15.9
523
3791
G04BX04
ATC
NA
6.5
15.9
41
65
1530
FHL
Urethrocystoscopy
7.1
15.7
38
55
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
2.3
15.5
159
757
N43.4
ICD-10 Finland
Spermatocele
15.0
15.4
25
17
TPH04
NOMESCO Finland
Cathetrisation of vein
1.9
15.4
255
1484
ZX100
NOMESCO Finland
Oral
6.0
15.4
42
72
Y77
ICPC
Malignant neoplasm prostate
3.4
15.3
76
236
K30
ICD-10 Finland
Functional dyspepsia
2.8
15.2
100
373
Z76.0
ICD-10 Finland
Issue of repeat prescription
2.3
15.1
144
662
A28
ICPC
Limited function/disability NOS
2.1
14.8
192
1016
N43.3
ICD-10 Finland
Hydrocele, unspecified
13.4
14.7
25
19
A02BC02
ATC
pantoprazole; systemic
1.6
14.6
658
5147
KED52
NOMESCO Finland
Visual laser resection of prostate
81.1
14.6
16
*
A02BC05
ATC
esomeprazole; systemic
1.7
14.4
384
2600
ZXA05
NOMESCO Finland
Left side
1.8
14.3
301
1895
J01MA01
ATC
ofloxacin; systemic
2.5
14.3
119
513
XX9BW
NOMESCO Finland
Submitting image material and/or investigation material to authority or other institution
10.6
14.3
27
26
WW200
SPAT
NA
2.6
14.2
110
455
R07.4
ICD-10 Finland
Chest pain, unspecified
1.8
14.2
285
1768
L02AE01
ATC
buserelin; implant, nasal, parenteral
43.0
14.1
17
*
U01
ICPC
Dysuria/painful urination
6.1
13.8
37
62
ZX120
NOMESCO Finland
Intravenous
2.4
13.8
124
556
KE002
NOMESCO Finland
Radical radiotherapy of prostata and seminal vesicles
14.9
13.6
22
15
K29
ICPC
Cardiovascular sympt/complt other
3.2
13.2
71
234
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.8
13.2
260
1597
RTGOM
NOMESCO Finland
NA
40.5
13.2
16
*
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
2.9
12.9
80
290
G04BD08
ATC
solifenacin; oral
3.3
12.9
64
199
U08
ICPC
Urinary retention
6.0
12.9
35
60
KDV12
NOMESCO Finland
Urethroscopic internal urethrotomy
8.2
12.8
28
35
M01AE01
ATC
ibuprofen; systemic, rectal
1.6
12.7
878
7524
KDV10
NOMESCO Finland
Internal urethrotomy
14.5
12.3
20
14
H25.1
ICD-10 Finland
Senile nuclear cataract
1.7
12.2
327
2198
Z01.9
ICD-10 Finland
Special examination, unspecified
3.2
12.1
63
203
KC1GB
NOMESCO Finland
Cystography with X-ray
5.5
12.1
35
65
XG405
NOMESCO Finland
Education on PEF monitoring
5.8
12.0
33
58
L03
ICPC
Low back symptom/complaint
1.9
11.9
182
1022
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
1.6
11.9
395
2810
308
Kela drug reimbursment
Alprostadil, sildenafil and combination product containing aviptadil and phentolamine
4.0
11.8
47
122
S59
ICPC
Skin, Other therap proced/minor surg NEC
5.9
11.8
32
55
N99.1
ICD-10 Finland
Postprocedural urethral stricture
14.8
11.8
19
13
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.6
11.7
427
3105
R53
ICD-10 Finland
Malaise and fatigue
1.8
11.7
201
1178
AA1AD
SPAT
NA
30.3
11.7
15
5
R1100
NOMESCO Finland
General evaluation of the need for rehabilitation
8.7
11.5
24
28
R22.9
ICD-10 Finland
Localized swelling, mass and lump, unspecified
3.0
11.5
67
234
N39.9
ICD-10 Finland
Disorder of urinary system, unspecified
7.4
11.3
26
36
ZYC01
SPAT
NA
3.2
11.2
59
193
N02AX02
ATC
tramadol; systemic, rectal
1.5
11.1
469
3519
ZXH01
NOMESCO Finland
Procedure performed within operation theatre
20.2
11.1
16
8
D19
ICPC
Teeth/gum symptom/complaint
1.8
11.1
194
1138
S01BC05
ATC
ketorolac; ophthalmic
2.7
11.1
76
292
N03AX16
ATC
pregabalin; oral
1.8
11.0
208
1253
XG410
NOMESCO Finland
Flow-volume spirometry
3.0
10.8
63
221
G04BD12
ATC
mirabegron; oral
2.4
10.7
90
387
A98
ICPC
Health maint/preventive medicine
1.6
10.7
939
8301
R50.9
ICD-10 Finland
Fever, unspecified
1.9
10.7
156
860
SAA01
NOMESCO Finland
Simple examination of mouth
1.5
10.7
568
4484
N30.9
ICD-10 Finland
Cystitis, unspecified
4.0
10.7
41
104
JN2CG
NOMESCO Finland
Extensive MRI examination of lower part of abdoment with high intensity magnet
5.4
10.6
31
59
YL1BD
NOMESCO Finland
Extensive CT examination of pelvis for dose design of radiotherapy
3.1
10.6
56
184
K40.9
ICD-10 Finland
Unilateral or unspecified inguinal hernia, without obstruction or gangrene
1.7
10.6
245
1573
S02.5
ICD-10 Finland
Fracture of tooth
4.3
10.5
38
91
UKD02
NOMESCO Finland
Urethroscopy
14.3
10.5
17
12
60200
ICD-8 Finland
Other diseases of prostate, Sclerosis colli vesicae urinariae
+∞
10.4
10
*
U29
ICPC
Urinary symptom/complaint other
4.9
10.4
33
69
N32.0
ICD-10 Finland
Bladder-neck obstruction
12.2
10.4
18
15
ZXA00
NOMESCO Finland
Right side
1.6
10.3
302
2063
J01MA12
ATC
levofloxacin; systemic
1.7
10.3
218
1357
SFA30
NOMESCO Finland
Filling on tree or more surfaces of tooth
1.6
10.2
342
2416
R10.2
ICD-10 Finland
Pelvic and perineal pain
6.7
10.2
25
38
WX110
NOMESCO Finland
Local anesthesy
1.5
10.2
596
4782
PJD64
NOMESCO Finland
Laparoscopic dissection of iliac lymph nodes
5.3
10.2
30
58
M75.1
ICD-10 Finland
Rotator cuff syndrome
1.7
10.2
226
1433
SDE02
NOMESCO Finland
Periodontal treatment by dental hygienist
1.8
10.1
182
1078
M01AC06
ATC
meloxicam; systemic, rectal
1.6
10.1
310
2145
A06AC01
ATC
ispaghula (psylla seeds); oral
1.8
9.8
193
1177
J01CA04
ATC
amoxicillin; systemic
1.5
9.7
746
6312
KFD20
NOMESCO Finland
Excision of hydrocele of testis
55.4
9.7
11
*
XKW99
NOMESCO Finland
Other physiological examination of urinary or male genital system
7.9
9.6
21
27
J01AA04
ATC
lymecycline; systemic
2.2
9.6
103
499
R30.0
ICD-10 Finland
Dysuria
4.6
9.6
32
71
J02AC01
ATC
fluconazole; systemic
1.8
9.6
181
1089
6028X
ICD-9 Finland
Other disorders of prostate, Other specified disorders of prostate
+∞
9.4
9
*
6029X
ICD-9 Finland
Other disorders of prostate, Unspecified disorder of prostate
+∞
9.4
9
*
60209
ICD-8 Finland
Other diseases of prostate, Unspecified
+∞
9.4
9
*
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
2.0
9.4
121
637
OAB42
SPAT
NA
3.1
9.3
50
167
B01AB10
ATC
tinzaparin; parenteral
2.4
9.3
76
325
ZX109
NOMESCO Finland
Instruction on medicine inhalation technique
8.8
9.3
19
22
N48.1
ICD-10 Finland
Balanoposthitis
4.7
9.2
30
65
R01AD11
ATC
triamcinolone; nasal
2.4
9.2
76
328
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
2.1
9.2
109
554
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.5
9.2
351
2550
M01AX01
ATC
nabumetone; oral
3.1
9.1
48
158
R29
ICPC
Respiratory symptom/complaint other
2.7
9.1
62
241
N30.2
ICD-10 Finland
Other chronic cystitis
11.6
9.1
16
14
S18
ICPC
Laceration/cut
1.5
9.1
408
3074
SFA10
NOMESCO Finland
Fillning on one surface of tooth
1.5
9.0
422
3203
G30.1
ICD-10 Finland
Alzheimer disease with late onset
2.3
9.0
85
390
D45
ICPC
Digestive, Observ/health educat/advice/diet
37.0
9.0
11
*
U05
ICPC
Urination problems other
3.1
9.0
47
154
AXX01
SPAT
NA
6.6
9.0
22
34
N32.82
ICD-10 Finland
Instability of the detrusor vesicae muscle
6.1
8.9
23
38
XCH00
NOMESCO Finland
Eye pressure measurement
2.8
8.9
56
206
R82.7
ICD-10 Finland
Abnormal findings on microbiological examination of urine
24.2
8.9
12
5
N42
ICD-10 Finland
Other disorders of prostate
24.2
8.9
12
5
SFA20
NOMESCO Finland
Filling on two surfaces of tooth
1.5
8.8
449
3466
M01AH01
ATC
celecoxib; oral (coxibs)
1.8
8.8
155
911
R05
ICPC
Cough
1.8
8.8
168
1012
XG404
NOMESCO Finland
Peak expiratory flow (PEF) measurement
8.7
8.8
18
21
L29
ICPC
Musculoskeletal sympt/complt other
2.6
8.8
63
251
M17.1
ICD-10 Finland
Other primary gonarthrosis
1.7
8.7
202
1290
Z46.1
ICD-10 Finland
Fitting and adjustment of hearing aid
2.1
8.7
93
453
KFD30
NOMESCO Finland
Operation for spermatocele
50.3
8.7
10
*
KMAK
NOMESCO Finland
NA
1.5
8.7
402
3038
R43
ICPC
Respiratory, Other diagnostic procedure
7.7
8.7
19
25
N27
ICPC
Fear of neurological disease other
5.3
8.6
25
48
TKW99
NOMESCO Finland
Other minor surgical procedure in urology
5.5
8.6
24
44
J01AA02
ATC
doxycycline; systemic
1.5
8.6
774
6671
EBA00
NOMESCO Finland
Extraction of tooth
1.5
8.6
302
2147
FP1B5
NOMESCO Finland
Resting ECG, 12 leads
5.0
8.5
26
53
K02.1
ICD-10 Finland
Caries of dentine
1.5
8.5
450
3499
ZXC96
NOMESCO Finland
Robot assisted procedure
3.2
8.4
43
139
R06AE09
ATC
levocetirizine; oral
2.1
8.4
97
486
S29
ICPC
Skin symptom/complaint other
1.8
8.4
151
891
WX144
NOMESCO Finland
Subconjunctival anesthesy
5.1
8.4
25
50
B02AA02
ATC
tranexamic acid; systemic
2.5
8.3
65
273
SFC01
NOMESCO Finland
Adjuvant procedure of filling therapy
1.6
8.3
225
1499
R06AE07
ATC
cetirizine; oral
1.5
8.3
297
2119
WZC30
NOMESCO Finland
Teaching
1.8
8.3
133
760
M25.5
ICD-10 Finland
Pain in joint
1.6
8.3
205
1335
S02.51
ICD-10 Finland
Fracture of tooth, open
2.2
8.2
84
400
XW5WT
NOMESCO Finland
Other blood specimen with radiologicl guidance
14.6
8.2
13
9
G54.4
ICD-10 Finland
Lumbosacral root disorders, not elsewhere classified
14.6
8.2
13
9
H29
ICPC
Ear symptom/complaint other
2.1
8.1
89
439
DFF30
NOMESCO Finland
Loudness discomfort Level (LDL)
3.2
8.1
41
132
R5120
NOMESCO Finland
Preparation of an aid
3.0
8.1
44
149
WNF00
NOMESCO Finland
Infection source and contact determination
8.2
8.1
17
21
Z29
ICPC
Social problem NOS
4.9
8.1
25
52
HMAK
NOMESCO Finland
NA
0.3
8.0
14
497
JAB30
NOMESCO Finland
Repair of inguinal hernia using prosthetic material
1.7
8.0
192
1238
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.7
7.9
157
958
NG1EA
SPAT
NA
13.1
7.9
13
10
A49.9
ICD-10 Finland
Bacterial infection, unspecified
1.8
7.9
140
825
U71
ICPC
Cystitis/urinary infection other
5.8
7.8
21
37
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
1.9
7.7
108
585
SAA02
NOMESCO Finland
Basic examination of mouth
1.4
7.7
476
3789
N48.8
ICD-10 Finland
Other specified disorders of penis
45.2
7.7
9
*
N30.4
ICD-10 Finland
Irradiation cystitis
45.2
7.7
9
*
N06DX01
ATC
memantine; oral
2.1
7.7
88
443
U06
ICPC
Haematuria
3.5
7.6
33
95
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
1.9
7.6
107
581
C09CA06
ATC
candesartan; oral
1.6
7.6
191
1244
G04BE03
ATC
sildenafil; oral
3.6
7.6
32
90
WX320
NOMESCO Finland
Spinalanesthesy
1.6
7.5
191
1250
ZXH09
SPAT
NA
4.6
7.4
24
53
G04BD11
ATC
fesoterodine; oral
4.1
7.4
27
67
TKE10
NOMESCO Finland
Puncture of prostate
5.3
7.4
21
40
N02AJ06
ATC
codeine and paracetamol; systemic
1.5
7.3
310
2287
XX3DW
NOMESCO Finland
Time consuming IT work
1.9
7.3
101
545
60009
ICD-8 Finland
Hyperplasia of prostate, Unspecified
+∞
7.3
7
*
60500
ICD-8 Finland
Redundant prepuce and phimosis, Phimosis
+∞
7.3
7
*
R10.1
ICD-10 Finland
Pain localized to upper abdomen
1.8
7.3
116
660
N05CF01
ATC
zopiclone; oral
1.5
7.3
318
2360
XCD10
NOMESCO Finland
Electrophysiological examination of eye
3.1
7.1
36
117
CJB10
NOMESCO Finland
Laser discission of secondary cataract
2.1
7.1
83
418
B01AB05
ATC
enoxaparin; parenteral
1.5
7.1
292
2136
N48.4
ICD-10 Finland
Impotence of organic origin
3.9
7.1
27
70
Y06
ICPC
Prostate symptom/complaint
2.6
7.1
49
192
UJF45
NOMESCO Finland
Flexible sigmoidoscopy with biopsy
2.0
7.1
85
435
Z87.1
ICD-10 Finland
Personal history of diseases of the digestive system
1.5
7.0
330
2480
UKC05
NOMESCO Finland
Cystoscopy and bladder biopsy
4.7
7.0
22
47
EB1AA
NOMESCO Finland
Tooth X-ray examination
1.4
7.0
434
3437
A02BA02
ATC
ranitidine; systemic
1.6
7.0
208
1417
K59.0
ICD-10 Finland
Constipation
2.4
7.0
58
252
WZC00
SPAT
NA
3.0
6.9
38
131
J02AC02
ATC
itraconazole; systemic
1.7
6.9
133
803
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
1.7
6.9
160
1019
D01BA02
ATC
terbinafine; oral; topical
1.5
6.9
266
1919
M54.9
ICD-10 Finland
Dorsalgia, unspecified
2.0
6.8
81
415
R21
NOMESCO Finland
Counselling and guidance in rehabilitation
5.3
6.8
19
36
R51
NOMESCO Finland
Aids services
40.3
6.8
8
*
Y50
ICPC
Male Genital, Medication/prescr/renewal
16.8
6.7
10
6
S12
ICPC
Insect bite/sting
2.2
6.7
67
318
U07
ICPC
Urine symptom/complaint other
2.8
6.7
41
152
KH1AD
NOMESCO Finland
CT of urinary organs
2.8
6.7
40
146
A07EA02
ATC
hydrocortisone; rectal
3.2
6.6
32
101
Z01.2
ICD-10 Finland
Dental examination
1.5
6.6
276
2025
M03BX02
ATC
tizanidine; oral
1.4
6.6
482
3925
SAA03
NOMESCO Finland
Extended examination of mouth
1.5
6.6
273
1998
CJE20
NOMESCO Finland
Phakoemulsification with implantation of artificial lens in posterior chamber
1.4
6.6
340
2601
TQW40
NOMESCO Finland
Remowal of suture of skin
2.2
6.6
66
315
N20.0
ICD-10 Finland
Calculus of kidney
3.2
6.5
32
103
H13
ICPC
Plugged feeling ear
1.6
6.4
185
1245
WF099
NOMESCO Finland
Other radiotherapy
7.4
6.4
14
19
KE099
NOMESCO Finland
Other radiotherapy of prostata and seminal vesicles
14.4
6.4
10
7
KF8AE
NOMESCO Finland
Ultrasound examination of scrotum
3.8
6.4
25
67
E78.01
ICD-10 Finland
Pure hypercholesterolaemia
1.5
6.4
211
1468
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.7
6.4
127
777
ZXH06
SPAT
NA
3.4
6.4
29
88
TKD00
NOMESCO Finland
Dilatation of urethra
8.2
6.3
13
16
KCE02
NOMESCO Finland
Transluminal endoscopic extraction of calculus from bladder
6.0
6.3
16
27
WZA90
NOMESCO Finland
Other doctors statement
1.6
6.3
172
1147
7322
FHL
TU cervical electrosection or discission
18.1
6.3
9
5
60208
ICD-8 Finland
Other diseases of prostate, Alii definiti
+∞
6.3
6
*
N48.6
ICD-10 Finland
Induratio penis plastica
+∞
6.3
6
*
Y29
ICPC
Genital symptom/complaint male other
6.3
6.2
15
24
JN3AE
SPAT
NA
5.4
6.2
17
32
J01.0
ICD-10 Finland
Acute maxillary sinusitis
1.8
6.1
106
619
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.6
6.1
160
1056
XF404
NOMESCO Finland
Ambulatory ECG
1.8
6.1
97
553
M01AX17
ATC
nimesulide; oral
1.5
6.1
224
1598
F51.0
ICD-10 Finland
Nonorganic insomnia
2.0
6.1
74
384
ZX022
NOMESCO Finland
LDR radiotherapy within tissue
12.6
6.1
10
8
A03
ICPC
Fever
1.8
6.1
97
555
WX000
NOMESCO Finland
Monitoring vital functions without anesthesy
2.6
6.1
41
162
J31.0
ICD-10 Finland
Chronic rhinitis
2.3
6.1
53
239
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.4
6.0
444
3605
G45.9
ICD-10 Finland
Transient cerebral ischaemic attack, unspecified
1.8
6.0
100
579

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3014051) Protein [Presence] in Urine by Test strip
144
170
9.37
114.44
2.6
2.1
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
201
364
6.32
109.00
1.2
1.2
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
450
1628
3.66
101.39
3.7
2.8
e6/l
0.5
1.0
4.79
357
951
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
403
1526
3.35
82.24
3.9
2.9
e6/l
0.4
0.5
0.74
307
864
(36304419) Bacteria [Presence] in Urine
553
2535
3.01
80.88
4.2
3.0
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
565
2645
2.96
79.18
4.1
3.1
e6/l
0.4
0.6
0.34
490
2018
(3031040) Bacteria [#/volume] in Urine by Automated count
890
5437
2.90
73.24
5.7
3.6
e6/l
131.2
2201.4
—
9
117
(3011397) Hemoglobin [Presence] in Urine by Test strip
453
1979
2.95
70.64
3.9
2.9
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
152
325
5.15
67.91
2.6
1.7
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
426
1863
2.89
65.57
3.5
2.7
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
395
1686
2.90
63.30
18.7
28.9
inr
1.1
1.5
—
8
255
(3002582) Erythrocytes [#/volume] in Urine
567
2939
2.61
61.69
4.4
3.1
e6/l
34.5
110.0
2.28
495
2312
(40758558) Short blood count panel - Blood
474
2250
2.71
61.68
6.5
6.9
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
600
3242
2.54
59.23
4.7
3.4
e6/l
63.4
80.8
0.40
516
2436
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
1014
7092
2.77
56.40
7.5
4.5
ug/l
5.0
3.5
0.90
940
6196
(3000330) Specific gravity of Urine by Test strip
158
459
3.77
46.97
2.9
3.4
—
—
—
0
0
(3022621) pH of Urine by Test strip
172
563
3.36
42.47
2.7
2.5
—
—
—
0
0
(3018418) pH of Serum or Plasma
486
2772
2.18
38.32
5.0
4.5
ph
7.4
7.4
0.02
42
527
(3037467) Urinalysis macro (dipstick) panel - Urine
828
5805
2.12
37.51
4.7
3.6
—
—
—
0
0
(3003338) MCHC [Mass/volume]
992
7466
2.27
37.33
26.6
21.8
g/l
333.1
333.7
1.18
983
7382
(3035350) Ketones [Presence] in Urine by Test strip
631
4029
2.07
36.49
4.1
3.0
estimate
0.0
0.0
0.00
66
710
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
800
5571
2.08
36.46
5.9
3.8
%
19.1
23.0
12.17
490
2576
(3021601) Nitrite [Presence] in Urine by Test strip
627
4020
2.05
35.58
5.1
4.0
estimate
0.0
0.0
0.00
66
739
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
247
1082
2.57
35.52
3.0
3.1
umol/l
6.9
11.4
4.54
233
977
(3009261) Glucose [Presence] in Urine by Test strip
632
4084
2.04
34.88
4.2
3.0
estimate
0.0
0.0
0.00
63
676
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
615
3941
2.04
34.69
3.6
2.6
ug/l
0.9
0.8
1.03
458
2551
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
167
624
2.91
32.59
1.8
1.5
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
244
1143
2.39
29.99
2.4
2.1
nmol/l
12.6
12.8
0.08
210
994
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
631
4310
1.88
27.44
7.2
6.8
mmol/l
1.2
1.2
0.70
611
3910
(3019150) Specific gravity of Urine by Refractometry
329
1838
2.05
25.71
4.3
3.2
kg/l
1.0
1.0
0.23
17
267
(3044889) 12 lead EKG panel
875
6709
1.88
25.56
4.4
4.2
—
—
—
0
0
(40761535) Cells panel - Urine sediment
176
768
2.49
25.04
3.6
3.1
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
243
1223
2.21
24.87
1.9
1.8
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
240
1224
2.17
23.67
1.9
1.8
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
483
3150
1.83
23.35
2.4
2.2
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
914
7217
1.84
23.00
24.3
20.3
%
13.9
13.9
0.08
902
7009
(3000850) Epithelial cells [#/volume] in Urine
341
2015
1.93
22.28
2.9
2.5
e6/l
2.1
3.1
4.33
303
1776
(4024509)
36
56
6.58
22.26
2.0
1.4
—
—
—
0
0
(4034850)
94
325
3.04
20.90
7.0
11.4
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
396
2532
1.80
19.80
3.6
4.6
%
83.4
80.2
1.59
387
2475
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
643
4726
1.69
19.42
6.9
7.5
mmol/l
1.2
1.2
1.29
591
3960
(3049717) Cytology report of Urine Cyto stain
108
431
2.64
18.37
3.0
2.9
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
580
4223
1.66
17.61
4.7
4.2
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
877
7113
1.67
17.23
8.6
8.0
u/l
79.1
82.1
0.75
847
6692
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
655
4939
1.64
17.16
6.4
6.8
umol/l
12.3
13.4
2.00
636
4707
(40761511) CBC panel - Blood by Automated count
1075
9249
1.82
16.74
19.0
15.8
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
546
3965
1.64
16.42
4.8
3.9
ng/l
56.7
64.1
0.24
464
3089
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
448
3115
1.66
15.88
4.5
3.2
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
745
5891
1.60
15.38
5.5
5.4
mmol/l
6.9
7.0
1.71
722
5560
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
568
4232
1.59
14.97
2.5
2.2
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
667
5168
1.58
14.80
8.0
9.0
e9/l
4.4
4.5
0.24
588
4482
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
414
2878
1.63
14.41
2.8
2.7
u/l
56.7
59.5
0.78
401
2667
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
1031
8945
1.66
13.43
20.6
16.9
mg/l
30.0
30.2
0.05
882
7310
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
133
675
2.08
12.97
1.8
1.7
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
927
7869
1.58
12.90
22.5
18.2
%
40.3
39.7
1.39
756
5191
(3003396) Base excess in Arterial blood by calculation
233
1430
1.76
12.75
5.4
7.7
mmol/l
0.8
0.8
0.01
184
1101
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
275
1776
1.69
12.50
1.9
1.9
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
148
815
1.92
11.44
3.3
2.9
ml/min/173m2
66.0
63.5
0.30
64
332
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
110
552
2.08
11.05
3.9
4.2
%
52.3
46.7
1.83
110
545
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
127
672
1.98
11.03
5.7
10.5
mmol/l
24.2
24.1
0.25
118
627
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
979
8541
1.54
10.90
18.4
15.9
ml/min/173m2
74.4
76.0
1.41
878
7091
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
40
1097
0.35
10.83
4.5
4.6
%
35.1
31.6
1.24
32
712
(3019550) Sodium [Moles/volume] in Serum or Plasma
1076
9606
1.61
10.67
23.6
19.9
mmol/l
139.6
139.6
0.25
1064
9333
(3021960) Folate [Moles/volume] in Serum or Plasma
335
2358
1.56
10.53
1.5
1.6
nmol/l
18.5
18.9
0.20
296
2037
(3023368) Bacteria identified in Blood by Culture
433
3227
1.50
10.44
4.6
4.6
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
442
3315
1.50
10.30
3.3
3.2
ng/l
2441.8
1928.3
0.73
394
2927
(3023103) Potassium [Moles/volume] in Serum or Plasma
1076
9638
1.59
10.17
23.6
20.1
mmol/l
4.1
4.0
0.82
1063
9353
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
68
290
2.42
10.11
1.4
1.8
—
—
—
0
0
(3020891) Body temperature
100
510
2.04
9.63
5.7
4.3
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
394
2927
1.49
9.47
3.6
3.5
u/l
37.4
46.0
0.50
377
2768
(3000991) Gas panel - Venous blood
169
1027
1.74
9.45
6.2
9.2
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
62
265
2.40
9.20
1.4
1.8
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
1099
9966
1.57
9.06
28.6
24.1
e9/l
6.9
7.1
2.11
1071
9595
(3007461) Platelets [#/volume] in Blood
1098
9962
1.57
8.96
28.5
24.0
e9/l
229.6
229.2
0.08
1079
9629
(3035941) MCH [Entitic mass]
1098
9963
1.57
8.94
28.4
23.9
pg
30.7
30.7
0.44
1090
9746
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
33
102
3.29
8.93
1.6
1.2
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
764
6467
1.42
8.93
4.1
3.8
mm/h
11.7
14.0
3.91
722
5908
(3026361) Erythrocytes [#/volume] in Blood
1098
9965
1.56
8.91
28.6
24.0
e12/l
4.5
4.5
1.83
1069
9591
(3024731) MCV [Entitic volume]
1098
9965
1.56
8.91
28.5
23.9
fl
91.8
91.9
0.27
1090
9748
(3000963) Hemoglobin [Mass/volume] in Blood
1098
9967
1.56
8.88
28.7
24.2
g/l
136.2
137.6
2.20
1091
9748
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
123
693
1.85
8.85
5.3
8.3
mmol/l
25.4
24.7
1.37
123
686
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
105
564
1.93
8.74
4.0
4.4
mmol/l
24.5
24.0
0.67
89
495
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1065
9627
1.52
8.54
11.3
10.9
u/l
25.3
28.8
9.29
1050
9229
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
299
2140
1.51
8.49
3.9
4.0
ng/l
289.7
548.0
1.91
282
1883
(3013512) EKG study
199
2906
0.63
8.22
4.2
4.2
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
982
8795
1.44
7.72
4.7
4.9
mmol/l
6.1
6.2
0.95
889
7894
(3013115) Eosinophils [#/volume] in Blood
566
4626
1.39
7.69
5.5
6.0
e9/l
0.2
0.2
0.04
505
4021
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
141
863
1.71
7.66
2.4
2.6
u/l
49.8
47.4
0.06
114
747
(3026782) Osmolality of Urine
265
1895
1.50
7.47
3.1
2.6
mosm/kgh2o
592.7
587.1
0.16
219
1614
(3003694) ABO and Rh group [Type] in Blood
329
2459
1.45
7.40
1.3
1.3
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
76
390
2.01
7.24
4.4
3.9
mmol/l
3.9
4.0
1.33
76
353
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
678
5756
1.36
7.05
3.1
3.0
pmol/l
15.2
15.0
1.25
606
5114
(3006315) Basophils [#/volume] in Blood
548
4512
1.36
6.89
5.2
5.7
e9/l
0.0
0.0
0.10
465
3859
(3019225) pH of Specimen
40
893
0.43
6.74
3.3
4.5
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
543
4488
1.35
6.57
5.2
5.7
e9/l
0.6
0.7
2.29
464
3827
(3002032) Base excess in Venous blood by calculation
170
1136
1.57
6.51
4.1
4.0
mmol/l
2.2
1.8
0.53
143
867
(3018677) aPTT in Platelet poor plasma by Coagulation assay
250
1814
1.46
6.49
2.1
2.1
s
30.6
30.5
0.09
245
1760
(3012544) pH of Venous blood
175
1186
1.55
6.30
3.9
4.0
—
7.4
—
0
8
(3019198) Lymphocytes [#/volume] in Blood
551
4589
1.34
6.25
5.3
5.9
e9/l
1.7
1.9
2.07
496
3984
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
858
7642
1.34
6.05
3.9
3.6
mu/l
2.0
2.1
1.16
773
6784
(3029937) Albumin [Presence] in Urine by Test strip
300
2289
1.40
5.86
5.3
3.2
estimate
0.0
0.0
0.50
61
637
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
493
4068
1.34
5.86
2.0
2.1
pmol/l
91.9
89.8
0.49
283
2335
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
94
556
1.74
5.80
3.3
2.6
%
0.7
0.7
0.20
87
530
(3019060) Gas panel - Arterial blood
129
837
1.60
5.61
4.1
4.6
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
502
4187
1.32
5.43
4.9
5.4
g/l
34.6
34.4
0.33
477
3864
(3018405) Lactate [Moles/volume] in Arterial blood
80
466
1.76
5.23
4.2
3.7
mmol/l
1.3
1.5
0.65
80
457
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
65
357
1.86
5.15
2.0
1.8
nmol/l
42.4
42.4
0.01
65
342
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
245
1845
1.40
5.12
1.7
1.7
mg/l
1.2
1.7
2.07
198
1453
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
989
9089
1.34
5.08
5.1
5.2
mmol/l
2.6
2.5
0.97
908
8283
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
967
8859
1.33
5.07
4.3
4.6
mmol/l
4.3
4.3
0.35
935
8130
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
326
2578
1.35
5.03
2.4
2.1
mg/l
3.2
3.0
0.30
293
2193
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
45
220
2.08
4.97
1.2
1.2
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
19
61
3.15
4.92
2.6
2.2
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
218
2866
0.71
4.88
2.9
3.2
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
16
454
0.34
4.72
1.5
2.0
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
107
696
1.58
4.63
2.1
2.5
ug/g
234.5
196.9
0.22
91
563
(3014765) Yersinia sp identified in Stool by Organism specific culture
44
220
2.03
4.60
1.2
1.2
—
—
—
0
0
(3008152) Bicarbonate [Moles/volume] in Arterial blood
118
788
1.55
4.56
7.7
6.7
mmol/l
24.1
24.2
0.05
111
736
(42529406) Shigella sp [Presence] in Stool by Culture
44
221
2.02
4.55
1.2
1.2
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
934
8568
1.30
4.52
5.7
6.5
mmol/mol
40.4
41.4
2.89
880
7846
(3001122) Ferritin [Mass/volume] in Serum or Plasma
407
3376
1.30
4.39
3.2
2.8
ug/l
184.7
218.4
1.15
383
3083
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
15
418
0.35
4.29
1.5
1.8
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
224
1721
1.36
4.11
2.5
3.3
mmol/l
2.4
2.4
0.01
175
1491
(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma
7
7
10.04
4.01
1.0
1.0
umol/l
3.9
1.7
—
7
7
(3022948) Iron [Moles/volume] in Serum or Plasma
217
1676
1.35
3.84
3.0
2.7
umol/l
12.4
12.6
0.19
204
1578
(3002256) Pathology report gross observation
149
1088
1.42
3.71
1.4
1.4
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
347
2894
1.27
3.48
3.3
3.4
mmol/l
2.3
2.3
0.28
309
2487
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
73
1108
0.64
3.45
4.2
3.5
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
944
8791
1.25
3.40
4.2
4.6
mmol/l
1.3
1.3
0.41
866
7992
(3021589) Normoblasts [#/volume] in Blood
461
3986
1.24
3.35
8.9
10.0
e9/l
0.0
0.0
0.71
367
3233
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
72
463
1.59
3.34
2.3
2.4
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
35
184
1.93
3.26
1.7
1.7
—
—
—
0
0
(44790047)
24
110
2.20
3.20
1.2
1.5
—
—
—
0
0
(44806118)
24
110
2.20
3.20
1.2
1.5
—
—
—
0
0
(44790048)
24
110
2.20
3.20
1.2
1.5
—
—
—
0
0
(44790049)
24
110
2.20
3.20
1.2
1.5
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
140
1045
1.38
3.09
1.3
1.2
iu/ml
17.7
49.5
4.50
44
303
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
67
434
1.57
3.04
2.8
2.6
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
916
8550
1.23
2.99
3.8
4.1
mmol/l
1.3
1.3
0.65
833
7719
(3025941) Bacteria identified in Stool by Culture
62
396
1.59
2.98
1.4
1.3
—
—
—
0
0
(4035726)
109
785
1.42
2.97
1.3
1.4
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
43
711
0.59
2.95
3.3
3.9
%
2.7
0.5
0.40
12
171
(42870588) Differential panel, method unspecified - Blood
367
3133
1.24
2.94
5.5
5.9
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
201
1596
1.31
2.94
3.1
2.7
g/l
2.1
2.2
0.99
187
1487
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
355
3026
1.24
2.88
2.0
2.0
nmol/l
80.5
75.2
2.88
310
2636
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
281
2340
1.25
2.81
2.6
2.8
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
148
1133
1.34
2.80
2.1
2.3
ug/l
6.2
8.9
1.92
142
1002
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
8
19
4.23
2.68
1.4
1.5
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
32
177
1.83
2.61
1.5
1.3
u/l
5.4
6.4
0.41
27
149
(3004716) Salmonella sp identified in Stool by Organism specific culture
46
284
1.64
2.57
1.2
1.2
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
49
751
0.64
2.48
3.2
4.0
%
0.2
0.2
0.04
20
235
(3001964) Herpes simplex virus Ag [Presence] in Specimen
7
16
4.39
2.47
1.4
1.7
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
54
351
1.56
2.46
2.3
1.6
—
—
—
0
0
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
6
12
5.02
2.40
1.5
2.1
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
44
681
0.63
2.34
3.3
4.1
%
0.1
0.1
0.02
14
185
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
187
1519
1.27
2.31
3.2
2.7
%
22.9
22.9
0.00
168
1339
(3018010) Neutrophils/100 leukocytes in Blood
473
4225
1.18
2.28
5.7
6.0
%
59.0
58.9
0.07
438
3966
(3005322) IgE [Units/volume] in Serum or Plasma
56
376
1.51
2.23
1.5
1.3
u/ml
712.7
307.4
0.47
51
335
(3002621) Streptococcal DNAse B [Units/volume] in Serum
5
9
5.57
2.21
1.0
1.2
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
138
1085
1.30
2.20
3.5
4.3
ug/l
8.3
35.1
2.01
112
925
(3043410) Blood group antigens tested for on Red Blood Cells
8
24
3.35
2.18
1.9
1.5
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
55
796
0.68
2.14
3.3
4.0
%
1.2
1.1
0.11
24
253
(3000494) Fungus identified in Specimen by Culture
132
1036
1.30
2.14
1.4
1.4
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
11
43
2.57
2.10
1.3
1.2
nmol/l
157.3
143.1
0.25
11
43
(3015183) Erythrocyte sedimentation rate
9
31
2.92
2.07
1.8
1.3
—
—
—
0
0
(4133840)
7
20
3.51
2.05
1.0
1.2
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
7
20
3.51
2.05
1.0
1.0
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
168
2037
0.80
1.99
1.8
1.8
nmol/l
1206.9
1145.4
0.47
143
1548
(3019069) Monocytes/100 leukocytes in Blood
468
4221
1.17
1.95
6.1
6.5
%
9.0
9.2
0.88
431
3956
(3002030) Lymphocytes/100 leukocytes in Blood
475
4296
1.16
1.90
5.9
6.2
%
25.4
25.3
0.07
436
4000
(3004119) Hemoglobin [Mass/volume] in Venous blood
95
725
1.33
1.90
3.8
3.3
g/l
128.8
128.4
0.06
95
707
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
22
121
1.83
1.89
1.6
1.5
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
0
53
0.00
1.87
0.0
1.9
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
0
53
0.00
1.87
0.0
1.9
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
0
53
0.00
1.87
0.0
1.9
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
0
53
0.00
1.87
0.0
1.9
—
—
—
0
0
(3018301) Testosterone Free [Moles/volume] in Serum or Plasma
18
93
1.95
1.85
1.5
1.3
pmol/l
117.1
402.8
—
6
27
(3006504) Eosinophils/100 leukocytes in Blood
465
4207
1.16
1.84
5.7
6.1
%
3.0
2.9
0.22
430
3930
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
26
152
1.72
1.84
1.3
1.5
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
20
108
1.86
1.82
1.1
1.3
u/ml
2.1
5.9
—
10
60
(3001019) Free T4 and TSH panel - Serum or Plasma
28
168
1.68
1.81
1.5
1.6
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
30
184
1.64
1.79
1.3
1.5
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
66
483
1.39
1.74
2.5
2.7
u/ml
0.3
0.3
0.95
39
258
(3022096) Basophils/100 leukocytes in Blood
452
4098
1.16
1.72
5.5
6.1
%
0.7
0.6
0.38
418
3840
(3044640) Blood type and Crossmatch panel - Blood
337
2990
1.17
1.71
2.7
2.9
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
125
1007
1.27
1.70
1.7
1.6
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
46
317
1.47
1.68
1.3
1.3
—
—
—
0
0
(3024263) Appearance of Synovial fluid
12
55
2.19
1.67
1.4
1.6
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
37
244
1.53
1.66
1.5
1.6
iu/ml
0.2
28.0
—
10
49
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
124
1001
1.26
1.66
1.3
1.2
u/ml
6.6
17.9
0.92
49
364
(3007566) Smooth muscle Ab [Titer] in Serum
12
234
0.51
1.56
1.0
1.2
—
96.2
—
0
21
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
94
739
1.29
1.56
1.6
1.7
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
56
407
1.39
1.56
2.7
2.5
g/l
3.1
3.1
0.04
47
325
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
5
15
3.34
1.52
1.0
1.0
—
—
—
0
0
(4306422)
19
109
1.75
1.47
1.3
1.2
—
—
—
0
0
(3034426) Prothrombin time (PT)
7
28
2.51
1.45
1.3
1.4
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
7
28
2.51
1.45
1.3
1.0
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
7
28
2.51
1.45
1.3
1.1
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
5
16
3.13
1.44
1.4
1.2
—
—
—
0
0
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
7
152
0.46
1.43
1.0
1.1
g/l
1.5
1.6
—
7
142
(3026389) Candida sp identified in Specimen by Organism specific culture
13
66
1.98
1.43
1.3
1.4
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
181
1548
1.20
1.42
2.1
2.2
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
59
441
1.35
1.41
2.7
2.5
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
59
441
1.35
1.41
2.7
2.5
g/l
3.9
4.0
0.38
46
318
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
9
179
0.50
1.40
8.8
3.6
%
49.9
58.8
—
9
179
(3006576) Bicarbonate [Moles/volume] in Blood
10
46
2.18
1.40
2.1
6.1
mmol/l
22.0
24.9
—
10
41
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
59
442
1.35
1.39
2.7
2.5
g/l
7.3
7.3
0.04
48
328
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
14
74
1.90
1.39
1.1
1.3
nmol/l
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
58
434
1.35
1.38
1.3
1.2
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
6
23
2.62
1.37
1.0
1.0
miu/ml
1683.2
1511.0
—
6
23
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
5
17
2.95
1.36
1.0
1.0
—
—
—
0
0
(3008037) Lactate [Moles/volume] in Venous blood
15
260
0.57
1.35
5.4
3.6
mmol/l
1.7
1.8
0.13
15
255
(3044290) Cell count panel - Cerebral spinal fluid
25
159
1.58
1.35
1.0
1.3
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
0
38
0.00
1.34
0.0
2.2
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
0
38
0.00
1.34
0.0
2.2
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
0
38
0.00
1.34
0.0
2.2
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
19
113
1.69
1.32
1.1
1.3
u/ml
1.4
3.8
—
8
48
(4268621)
14
76
1.85
1.30
2.1
2.4
—
—
—
0
0
(3028271) Lactate [Moles/volume] in Capillary blood
9
175
0.51
1.29
2.6
2.0
mmol/l
1.7
1.8
—
9
170
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
42
302
1.40
1.28
1.9
1.6
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
12
62
1.94
1.28
1.1
1.0
u/ml
0.2
0.7
—
7
22
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
11
55
2.01
1.27
1.1
1.2
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
11
55
2.01
1.27
1.1
1.2
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
18
107
1.69
1.26
1.1
1.1
—
—
—
0
0
(3004775) Volume in Urine collected for unspecified duration
5
118
0.42
1.25
2.0
2.0
ml
868.0
666.6
—
5
59
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
13
70
1.87
1.24
1.1
1.1
u/ml
0.4
3.3
—
7
26
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
9
45
2.01
1.23
2.4
1.6
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
59
756
0.77
1.17
6.9
4.3
mmol/l
1.2
1.2
1.18
49
671
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
10
50
2.01
1.16
1.5
2.7
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
68
536
1.28
1.16
3.5
3.9
e9/l
4.4
4.7
0.17
61
384
(36660697) Celiac disease serology panel - Serum
57
439
1.31
1.16
1.2
1.1
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
8
39
2.06
1.15
1.0
1.2
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
8
39
2.06
1.15
1.4
1.5
—
—
—
0
0
(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection
0
36
0.00
1.14
0.0
2.1
—
550.0
—
0
6
(21494890) Protein electrophoresis panel - 24 hour Urine
20
127
1.58
1.11
2.4
2.3
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
54
416
1.31
1.10
2.1
2.5
g/l
10.4
10.8
0.45
48
351
(3026493) Urate [Moles/volume] in Serum or Plasma
310
2820
1.13
1.09
3.4
2.9
umol/l
1840.5
6786.5
2.20
266
2424
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
14
81
1.74
1.09
1.1
1.3
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
26
177
1.48
1.08
1.3
1.1
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
83
678
1.24
1.07
6.5
10.9
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
11
59
1.87
1.07
1.5
2.7
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
17
265
0.64
1.05
3.9
3.7
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
5
22
2.28
1.03
1.0
1.0
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
42
316
1.34
1.02
3.7
3.9
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
9
47
1.92
1.02
3.1
2.3
—
—
—
0
0
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
26
180
1.45
1.01
1.5
1.2
mmol/l
3.7
3.8
0.22
26
166
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
18
115
1.57
0.99
1.0
1.1
—
—
—
0
0
(21494434) Karyotype in Bone marrow
18
115
1.57
0.99
1.0
1.2
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
150
1307
1.17
0.99
1.2
1.2
u/ml
4.2
1.5
0.75
39
344
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
25
173
1.45
0.98
1.2
1.2
—
—
—
0
0
(40757494) Bilirubin.total [Moles/volume] in Blood
12
69
1.75
0.96
2.6
1.9
—
38.8
—
0
5
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
0
31
0.00
0.96
0.0
1.1
—
15.1
—
0
26
(3015171) Extractable nuclear Ab [Units/volume] in Serum
32
233
1.38
0.96
1.0
1.2
u/ml
0.4
1.3
0.60
15
25
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
98
826
1.20
0.96
1.7
1.5
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
186
2084
0.88
0.94
1.7
1.7
pmol/l
422.5
35722878.1
2.14
166
1744
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
7
37
1.90
0.94
1.1
1.1
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
90
1066
0.83
0.92
3.1
2.9
ng/l
272.9
256.8
0.11
82
979
(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma
10
55
1.82
0.92
1.7
3.8
nmol/l
64.6
74.8
—
10
55
(40760892) CBC W Ordered Manual Differential panel - Blood
205
1842
1.13
0.90
4.4
4.5
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
44
344
1.29
0.85
1.4
1.5
—
—
—
0
0
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
25
179
1.40
0.84
1.4
1.4
e6/l
4.8
29.2
0.79
20
144
(3004588) Protein electrophoresis panel - Serum or Plasma
89
756
1.19
0.82
2.7
2.5
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
23
163
1.42
0.82
1.4
1.3
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
6
32
1.88
0.82
1.2
2.1
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
110
953
1.17
0.81
2.9
2.6
g/l
66.7
66.2
0.30
103
870
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
13
81
1.61
0.81
1.0
1.1
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
29
215
1.36
0.81
1.3
1.5
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
22
156
1.42
0.79
1.3
1.4
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
8
48
1.67
0.78
1.6
1.2
iu/l
11.4
13.3
—
8
35
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
20
140
1.44
0.77
2.8
3.2
—
—
—
0
0
(3009466) Valproate [Moles/volume] in Serum or Plasma
19
132
1.45
0.76
4.7
4.7
umol/l
351.8
326.6
0.24
14
113
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
10
59
1.70
0.76
2.6
2.9
—
—
—
0
0
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
11
67
1.65
0.75
1.5
1.3
—
—
—
0
0
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
5
24
2.09
0.74
15.0
9.2
mmol/l
6.3
5.3
—
5
24
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
5
24
2.09
0.74
1.0
1.1
—
—
—
0
0
(3014891) Appearance of Pleural fluid
5
24
2.09
0.74
1.6
1.3
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
5
24
2.09
0.74
1.0
1.1
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
8
132
0.60
0.73
7.1
4.1
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
21
150
1.41
0.73
1.3
1.6
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
5
25
2.00
0.72
1.4
1.7
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
11
171
0.64
0.72
1.0
1.1
—
93.8
—
0
33
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
7
40
1.75
0.71
1.0
1.2
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
7
40
1.75
0.71
1.0
1.2
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
22
160
1.38
0.70
2.4
2.0
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
28
364
0.76
0.69
1.8
2.2
ug/min
252.0
91.8
0.53
22
210
(3020682) Albumin/Creatinine [Ratio] in Urine
326
3473
0.92
0.66
3.5
4.1
mg/mmol
13.6
9.6
0.48
232
2421
(3023520) Reticulocytes [#/volume] in Blood
119
1057
1.14
0.66
2.7
2.4
e9/l
69.5
68.2
0.17
106
803
(3020779) Urea [Moles/volume] in Serum or Plasma
127
1133
1.13
0.66
8.0
7.6
mmol/l
12.1
11.2
0.65
119
1072
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
7
44
1.59
0.65
1.0
1.0
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
432
4545
0.93
0.64
8.4
11.9
inr
1.4
1.4
0.20
100
1229
(3024891) Influenza virus A+B Ag [Presence] in Specimen
27
207
1.31
0.64
1.4
1.2
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
6
102
0.59
0.62
1.8
1.5
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
30
235
1.28
0.61
1.6
1.7
e6/l
15959.0
12915.5
0.14
22
171
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
22
165
1.34
0.60
3.2
2.8
—
2510.3
—
0
16
(4010399)
54
639
0.84
0.60
1.6
1.3
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
0
20
0.00
0.60
0.0
1.3
—
—
—
0
0
(3043870) Heparin induced platelet Ab [Units/volume] in Serum
0
20
0.00
0.60
0.0
1.1
—
—
—
0
0
(3020191) Ethanol [Moles/volume] in Serum or Plasma
12
80
1.50
0.60
1.3
1.5
promille
1.8
1.2
0.70
12
63
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
211
2279
0.91
0.59
1.6
1.6
mmol/l
1.3
1.4
0.78
166
1899
(3009445) Proteinase 3 Ab [Units/volume] in Serum
50
418
1.20
0.59
1.2
1.4
—
17.7
—
0
10
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
0
22
0.00
0.59
0.0
1.1
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
0
22
0.00
0.59
0.0
1.1
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
0
22
0.00
0.59
0.0
1.1
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
0
22
0.00
0.59
0.0
1.1
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
30
237
1.27
0.58
1.3
1.7
—
—
—
0
0
(44786800) Granulocytes/100 leukocytes in Body fluid
0
23
0.00
0.58
0.0
1.7
—
7.9
—
0
15
(3008757) Leukocyte morphology finding [Identifier] in Blood
7
114
0.61
0.58
2.0
4.1
—
—
—
0
0
(3026692) Albumin [Mass/volume] in Peritoneal fluid
6
35
1.72
0.57
2.3
1.5
g/l
14.6
11.3
—
6
28
(3033705) Calcium.ionized [Moles/volume] in Venous blood
10
149
0.67
0.56
4.0
2.8
—
—
—
0
0
(40768443) Skin Pathology biopsy report
42
347
1.22
0.56
1.0
1.3
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
5
90
0.55
0.55
1.6
1.7
—
—
—
0
0
(4027681)
6
37
1.62
0.55
1.0
1.2
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
21
159
1.33
0.55
1.1
1.1
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
8
122
0.65
0.55
2.0
1.2
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
133
1207
1.11
0.54
1.8
1.8
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
6
38
1.58
0.54
2.8
1.9
—
—
—
0
0
(44813793)
6
38
1.58
0.54
1.2
1.0
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
6
38
1.58
0.54
1.8
1.3
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
11
74
1.49
0.53
1.4
1.4
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
221
2060
1.09
0.53
3.6
2.9
—
—
—
0
0
(3012501) Base excess in Blood by calculation
20
260
0.77
0.53
3.4
5.5
mmol/l
2.3
2.6
0.17
12
173
(3027944) Amphetamines [Presence] in Urine
16
117
1.37
0.52
2.6
2.0
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
20
152
1.32
0.52
1.9
1.5
—
—
—
0
0
(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination
6
98
0.61
0.52
1.8
2.0
—
592.0
—
0
5
(3007164) IgA [Mass/volume] in Serum or Plasma
139
1269
1.11
0.51
1.3
1.6
g/l
2.5
3.1
3.19
76
793
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
79
698
1.14
0.50
1.3
1.3
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
36
297
1.22
0.50
4.6
3.9
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
71
624
1.15
0.49
1.4
1.5
g/l
1.6
1.5
0.18
62
525
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
26
208
1.25
0.48
1.5
1.2
mg/l
699.2
561.1
0.54
26
189
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
7
47
1.49
0.47
1.0
1.2
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
7
48
1.46
0.47
1.0
1.2
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
7
48
1.46
0.47
1.0
1.2
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
7
48
1.46
0.47
1.0
1.2
—
—
—
0
0
(3036489) Thrombin time
43
365
1.18
0.46
1.6
2.1
s
21.6
21.7
0.10
36
338
(3028300) Cannabinoids [Presence] in Urine
16
120
1.34
0.46
2.9
2.0
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
16
120
1.34
0.46
2.6
2.0
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
32
264
1.22
0.46
1.0
1.0
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
13
176
0.74
0.46
2.2
1.7
—
—
—
0
0
(3024474) Albumin [Mass/volume] in Cerebral spinal fluid
7
49
1.43
0.46
1.0
1.0
mg/l
296.7
339.3
—
7
44
(3032773) Endomysium IgG Ab [Titer] in Serum
7
49
1.43
0.46
1.1
1.0
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
7
49
1.43
0.46
1.0
1.1
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
30
246
1.22
0.45
1.7
1.7
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
7
50
1.40
0.45
1.0
1.2
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
7
50
1.40
0.45
1.0
1.2
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
7
50
1.40
0.45
1.0
1.2
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
16
121
1.33
0.44
1.3
1.0
—
—
—
0
0
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
7
51
1.37
0.44
1.1
1.1
mg/l
44.0
56.5
—
7
43
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
26
211
1.24
0.43
6.2
5.6
iu/ml
99.2
7376.0
—
5
34
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
21
166
1.27
0.43
1.2
1.5
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
22
175
1.26
0.43
1.5
1.5
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
156
1449
1.09
0.42
7.4
6.8
mmol/l
1.0
1.0
0.10
148
1349
(3042733) HLA Ab [Presence] in Serum
5
32
1.56
0.42
6.0
5.3
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
8
57
1.41
0.42
1.5
1.7
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
31
258
1.21
0.42
1.9
1.6
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
18
140
1.29
0.42
1.2
1.2
u/ml
296.4
264.1
0.18
13
80
(3040370) OLANZapine [Moles/volume] in Serum or Plasma
5
33
1.52
0.41
2.6
2.4
nmol/l
101.6
127.3
—
5
27
(3011335) Digoxin [Mass/volume] in Serum or Plasma
0
15
0.00
0.41
0.0
3.1
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
0
15
0.00
0.41
0.0
1.0
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
0
15
0.00
0.41
0.0
1.2
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
0
16
0.00
0.41
0.0
1.5
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
0
16
0.00
0.41
0.0
1.7
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
25
204
1.23
0.40
1.2
1.5
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
11
79
1.40
0.40
1.0
1.2
—
—
—
0
0
(3052592) Norovirus Ag [Presence] in Stool
0
17
0.00
0.40
0.0
1.3
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
5
34
1.47
0.40
1.0
1.1
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
11
149
0.74
0.40
1.1
1.0
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
7
101
0.69
0.39
1.7
1.5
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
7
101
0.69
0.39
1.7
1.5
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
7
103
0.68
0.39
1.6
1.5
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
7
103
0.68
0.39
1.7
1.5
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
13
97
1.34
0.39
1.7
1.6
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
5
35
1.43
0.39
11.4
7.9
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
5
35
1.43
0.39
1.2
1.1
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
5
35
1.43
0.39
1.2
2.4
—
—
—
0
0
(3021162) Amylase [Enzymatic activity/volume] in Specimen
0
19
0.00
0.39
0.0
3.1
—
2046.4
—
0
19
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
32
270
1.19
0.38
1.4
1.4
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
11
80
1.38
0.38
2.0
2.3
—
—
—
0
0
(3022145) Colonoscopy Study observation
101
925
1.10
0.38
1.3
1.4
—
—
—
0
0
(3017704) Immunofixation for Urine
9
66
1.37
0.38
1.6
1.5
—
—
—
0
0
(3018980) carBAMazepine [Moles/volume] in Serum or Plasma
5
36
1.39
0.38
4.6
2.3
umol/l
25.2
31.5
—
5
25
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
9
69
1.31
0.37
1.1
1.2
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
44
503
0.87
0.37
1.4
1.4
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
5
37
1.35
0.37
3.4
3.0
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
8
115
0.69
0.37
1.1
1.1
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
16
125
1.28
0.37
1.3
1.7
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
26
216
1.21
0.37
1.7
1.5
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
30
253
1.19
0.37
1.2
1.7
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
153
1432
1.08
0.36
2.4
2.2
%
1.7
1.8
0.18
145
1264
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
11
81
1.36
0.36
1.0
1.0
ng/l
216.2
299.0
—
6
44
(3011288) Drugs identified in Urine by Screen method
11
81
1.36
0.36
4.8
2.6
—
—
—
0
0
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
11
81
1.36
0.36
1.0
1.0
ng/l
1146.7
661.8
—
6
42
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
11
81
1.36
0.36
1.0
1.0
ng/l
27.2
43.7
—
6
42
(3003740) Influenza virus B Ag [Presence] in Specimen
5
77
0.65
0.35
1.2
1.1
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
5
78
0.64
0.35
1.2
1.1
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
6
42
1.43
0.35
1.0
1.2
iu/ml
120.4
249.4
—
6
42
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
20
163
1.23
0.34
1.4
1.3
—
—
—
0
0
(1616796) Gas panel - Central venous blood
32
274
1.17
0.34
2.7
4.1
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
117
1258
0.92
0.34
10.4
7.7
—
—
—
0
0
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
50
444
1.13
0.33
2.8
4.1
mmol/l
24.8
24.7
0.07
50
406
(44816559) Phosphatidylethanol [Mass/volume] in Blood
12
155
0.77
0.33
1.0
1.4
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
61
676
0.90
0.33
6.5
3.2
—
—
—
0
0
(3023183) Ammonium ion [Moles/volume] in Plasma
25
296
0.84
0.33
3.4
3.1
umol/l
25.6
38.6
1.92
20
248
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
63
569
1.11
0.32
2.1
2.0
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
26
220
1.19
0.32
2.0
1.7
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
15
119
1.26
0.32
2.9
2.0
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
7
100
0.70
0.30
1.7
1.5
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
15
185
0.81
0.30
1.6
1.4
—
—
—
0
0
(4094501)
30
260
1.16
0.29
1.1
1.1
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
10
76
1.32
0.28
1.0
1.1
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
12
94
1.28
0.28
3.6
1.7
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
8
62
1.29
0.28
1.0
1.1
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
126
1186
1.07
0.27
1.2
1.3
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
113
1060
1.07
0.27
1.8
1.9
%
1.5
1.7
1.40
96
900
(3016879) Cocaine [Presence] in Urine
14
113
1.24
0.26
2.8
2.0
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
18
150
1.20
0.26
1.2
1.2
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
187
1791
1.05
0.24
2.8
3.3
mmol/l
0.8
0.8
0.29
179
1693
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
11
87
1.27
0.24
1.0
1.1
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
21
244
0.86
0.24
3.7
2.8
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
15
124
1.21
0.24
1.2
1.2
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
12
97
1.24
0.23
1.1
1.8
—
—
—
0
0
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
5
40
1.25
0.22
2.4
4.7
—
20.8
—
0
11
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
5
40
1.25
0.22
11.4
7.6
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
7
95
0.74
0.22
1.1
1.1
—
—
—
0
0
(4211845)
5
41
1.22
0.22
3.4
3.0
—
—
—
0
0
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
17
199
0.85
0.21
1.2
1.2
—
42.5
—
0
8
(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine
0
11
0.00
0.21
0.0
3.5
—
—
—
0
0
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
0
10
0.00
0.21
0.0
1.1
—
52.9
—
0
10
(3008691) Amylase [Enzymatic activity/volume] in Peritoneal fluid
0
10
0.00
0.21
0.0
1.3
—
6717.1
—
0
10
(3036525) Urea [Moles/time] in 24 hour Urine
0
10
0.00
0.21
0.0
2.5
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.8
—
14.4
—
0
10
(4212803)
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3009015) Lactate [Moles/volume] in Synovial fluid
0
12
0.00
0.21
0.0
1.2
—
8.2
—
0
7
(3016650) Hepatitis A virus Ab [Presence] in Serum
12
145
0.83
0.21
1.1
1.1
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
11
89
1.24
0.21
1.0
1.1
—
—
—
0
0
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
0
14
0.00
0.20
0.0
1.2
—
—
—
0
0
(1002224) Polysomnography panel
26
292
0.89
0.20
1.0
1.1
—
—
—
0
0
(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma
6
49
1.23
0.20
1.3
1.1
u/l
38.3
20.1
—
6
39
(3009343) pH of Capillary blood
70
747
0.93
0.20
3.1
3.7
ph
7.4
7.4
—
9
78
(3012441) Differential panel - Pleural fluid
15
176
0.85
0.20
2.1
1.6
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
6
50
1.20
0.19
1.3
1.2
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
16
186
0.86
0.19
2.6
2.5
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
10
81
1.24
0.18
1.0
1.1
—
—
—
0
0
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
6
53
1.13
0.18
1.2
2.3
u/l
189.8
217.7
—
6
53
(3017569) Oxygen content in Arterial blood
5
68
0.73
0.17
1.0
2.7
—
—
—
0
0
(3004451) EKG impression Narrative
5
69
0.72
0.17
1.6
1.3
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
96
915
1.05
0.16
1.2
1.3
titre
296.5
366.6
0.42
17
183
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
8
70
1.14
0.16
1.0
1.0
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
8
72
1.11
0.16
1.0
1.3
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
8
73
1.10
0.15
1.6
4.8
—
—
—
0
0
(3000492) Spirometry study
82
780
1.05
0.15
1.4
1.5
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
6
78
0.77
0.15
1.2
1.5
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
6
80
0.75
0.15
1.0
1.1
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
9
79
1.14
0.15
1.1
1.4
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
329
3352
0.98
0.13
3.1
3.2
mmol/l
8.1
8.5
0.96
281
2801
(3011648) Oxygen content in Venous blood
8
99
0.81
0.13
2.4
1.9
%
9.9
11.0
—
8
99
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
96
999
0.96
0.13
1.9
2.4
g/l
0.2
0.2
0.06
89
914
(3035880) pH of Pleural fluid
11
94
1.17
0.13
1.4
1.4
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
21
190
1.11
0.12
1.2
1.2
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
24
220
1.09
0.12
1.4
1.6
ug/g
233.4
240.2
0.07
14
150
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
12
105
1.14
0.11
1.1
1.7
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
32
342
0.93
0.11
2.3
1.7
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
69
719
0.96
0.10
3.0
3.6
mmol/l
2.3
1.8
0.40
50
513
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
5
48
1.04
0.09
1.6
1.5
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
5
48
1.04
0.09
2.0
2.9
—
—
—
0
0
(3023199) Leukocytes [#/volume] in Pleural fluid
21
194
1.08
0.09
2.0
1.5
e6/l
1597.7
1702.5
0.05
15
140
(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma
6
54
1.11
0.09
1.3
1.1
u/l
87.8
95.8
—
6
44
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
19
175
1.09
0.08
1.1
1.2
—
—
—
0
0
(40768441) Liver Pathology biopsy report
5
62
0.81
0.08
1.0
1.6
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
5
64
0.78
0.08
1.2
1.7
—
—
—
0
0
(4062490)
7
66
1.06
0.08
1.6
1.2
—
—
—
0
0
(3024139) IgG subclass 3 [Mass/volume] in Serum
7
67
1.05
0.08
1.6
1.2
g/l
0.4
0.5
—
7
49
(3027135) IgG subclass 1 [Mass/volume] in Serum
7
67
1.05
0.08
1.6
1.2
g/l
6.0
7.6
—
7
48
(3028192) IgG subclass 2 [Mass/volume] in Serum
7
67
1.05
0.08
1.6
1.2
g/l
3.3
3.2
—
7
49
(21494815) CD4 cells/100 lymphocytes in Specimen
6
71
0.84
0.07
1.3
2.0
—
35.9
—
0
7
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
6
70
0.86
0.07
4.8
3.2
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
6
70
0.86
0.07
1.5
1.3
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
6
70
0.86
0.07
1.5
1.3
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
20
186
1.08
0.07
1.2
1.8
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
10
112
0.89
0.07
1.2
1.3
—
—
—
0
0
(3026470) Cobalt [Mass/volume] in Blood
7
81
0.86
0.07
2.0
1.8
ug/l
1.4
3.4
—
7
67
(3016018) Differential panel - Cerebral spinal fluid
9
87
1.03
0.07
1.0
1.2
—
—
—
0
0
(3008295) Osmolality of Serum or Plasma
8
93
0.86
0.06
1.4
1.2
mosm/kgh2o
262.8
279.7
—
8
71
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
36
344
1.05
0.06
1.1
1.3
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
9
104
0.86
0.06
1.8
4.6
—
—
—
0
0
(3022313) Gas panel - Capillary blood
53
548
0.97
0.06
3.1
3.8
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
24
227
1.06
0.06
1.2
1.4
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
79
808
0.98
0.05
1.8
1.7
—
—
—
0
0
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
11
100
1.10
0.05
1.0
1.2
mmol/l
11.6
7.4
—
5
78
(3035637) Corticotropin [Mass/volume] in Plasma
11
100
1.10
0.05
1.4
1.6
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
327
3295
0.99
0.04
3.4
3.3
mg/l
546.0
168.7
0.75
256
2324
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
16
150
1.07
0.04
1.3
1.5
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
10
91
1.10
0.04
1.1
1.2
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
26
249
1.05
0.04
1.5
1.7
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
34
351
0.97
0.03
4.3
6.4
mmol/l
1.2
1.4
1.55
29
315
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
564
5618
1.01
0.03
2.8
3.3
u/l
52.6
65.5
2.03
538
5162
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
80
813
0.98
0.03
1.9
1.6
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
27
261
1.04
0.02
2.1
2.8
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
51
520
0.98
0.02
1.5
1.5
—
—
—
0
0
(3028308) Erythrocytes [#/volume] in Pleural fluid
19
182
1.04
0.02
2.1
1.5
e6/l
9611.1
50196.4
1.74
11
115
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
18
174
1.03
0.00
1.7
1.4
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
21
216
0.97
0.00
1.5
1.5
mg/l
2.3
3.4
—
10
154
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
33
326
1.01
0.00
2.0
2.3
g/l
3.9
3.7
0.28
33
306
(3044927) Protein electrophoresis panel - Urine
10
98
1.02
0.00
1.3
1.2
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
24
239
1.00
0.00
1.7
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
24
239
1.00
0.00
1.7
1.3
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
30
301
1.00
0.00
1.4
1.4
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
13
133
0.98
0.00
1.2
1.2
—
—
—
0
0
(3008898) HLA-B27 [Presence]
15
147
1.02
0.00
1.0
1.1
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
28
277
1.01
0.00
1.1
1.2
iu/ml
31.5
122.5
—
7
91
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
14
145
0.97
0.00
1.1
1.3
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
10
105
0.95
0.00
2.4
3.2
—
—
—
0
0
(3025549) Creatine [Moles/time] in 24 hour Urine
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(36305075) Vedolizumab [Mass/volume] in Serum or Plasma by Immunoassay
0
7
0.00
0.00
0.0
2.3
—
18.7
—
0
7
(3047189) Immunofixation for 24 hour Urine
6
65
0.92
0.00
1.0
1.9
—
—
—
0
0
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
5
57
0.88
0.00
2.4
2.2
e6/l
645.6
454.1
—
5
47
(3041678) Intrinsic coagulation system thromboelastography panel - Blood
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
8
83
0.96
0.00
1.0
1.0
—
102.5
—
0
8
(3018834) Bilirubin.total [Presence] in Urine by Test strip
0
7
0.00
0.00
0.0
2.9
—
—
—
0
0
(3045462) Protein/Creatinine [Ratio] in Urine
0
7
0.00
0.00
0.0
4.9
—
35.1
—
0
7
(3013762) Body weight Measured
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
9
89
1.01
0.00
1.2
1.1
u/l
54.2
63.6
—
9
61
(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis
0
9
0.00
0.00
0.0
3.0
—
—
—
0
0
(1175426) CD3 cells/100 lymphocytes in Blood
5
59
0.85
0.00
1.2
2.0
%
65.0
72.4
—
5
54
(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture
0
5
0.00
0.00
0.0
3.2
—
—
—
0
0
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
39
390
1.00
0.00
4.9
3.8
ratio
2.5
6.1
—
8
24
(3016330) Potassium [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
9
92
0.98
0.00
1.1
1.7
—
—
—
0
0
(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
6
64
0.94
0.00
1.0
1.2
—
—
—
0
0
(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3025577) Chromium [Mass/volume] in Blood
7
77
0.91
0.00
2.0
1.9
ug/l
1.1
1.7
—
7
66
(3009677) Dengue virus Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
9
92
0.98
0.00
1.1
1.7
—
—
—
0
0
(3020393) Adenovirus Ag [Presence] in Stool
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
9
92
0.98
0.00
1.1
1.7
—
—
—
0
0
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma
0
6
0.00
0.00
0.0
2.3
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
5
53
0.94
0.00
1.2
2.0
—
—
—
0
0
(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0

Mortality – FinRegistry

↥

Association

Association between endpoint N14_PROSTAOTH and mortality.

Females

No data

Males

Parameter HR [95% CI] p-value
N14_PROSTAOTH 1.179 [1.08, 1.29] < 0.001
Birth year 0.988 [0.98, 1.0] 0.01

During the follow-up period (1.1.1998 — 31.12.2019), 2797 out of 7873 males with N14_PROSTAOTH died.

Mortality risk

Mortality risk for people of age

years, who have N14_PROSTAOTH.

N-year risk Females Males
1 No data 0.215%
5 No data 1.531%
10 No data 3.6%
15 No data 6.648%
20 No data 11.126%

Relationships between endpoints

↥

Index endpoint: N14_PROSTAOTH – Other disorders of prostate

GWS hits: 3

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data